Healthcare -
Biotechnology - NASDAQ - US
$ 2.47
3.78 %
$ 119 M
Market Cap
-1.79
P/E
SAVA - RESEARCH & DEVELOPMENT
Research & Development SAVA - Cassava Sciences, Inc.
89.4 M
LAST VALUE
89.84%
2 YEAR CAGR
97.59%
5 YEAR CAGR
33.65%
10 YEAR CAGR